ERBB2 and breast adenocarcinoma: For in vitro targeting experiments, two cell lines with different expression levels of HER2 receptor were selected: (i) human breast adenocarcinoma cell line SK-BR-3 with an overexpression of HER2 receptor; (ii) Chinese hamster ovary cell line CHO without the expression of HER2.